Suppr超能文献

[化疗疗程期间经隧道式中心静脉导管留置给药。98例门诊患者的前瞻性研究]

[Chemotherapy via tunneled central venous catheter left in place between drug courses. Prospective study in 98 ambulatory patients].

作者信息

Vedrenne J B, Estève M, Pouillart P, Quinet A

出版信息

Bull Cancer. 1985;72(3):236-9.

PMID:4074908
Abstract

Chemotherapy is normally given during several months and requires a good vascular access. Repeated injections of cytotoxic agents are harmful for peripheral veins. We report here a prospective study on 98 ambulatory patients provided with a tunneled central venous catheter left in situ between drug administration. The catheter is inserted either in the subclavian or the internal jugular vein. Between chemotherapy drugs injection, heparin is given once a week in the catheter. Among the several advantages reported with this technique: easiness of drug injection, comfort of patients, possibility of new insertions in an other site in case of occlusion and the low cost. This technique is a "routine" at the Institut Curie since 5 years. Advantages and side effects of this technique are compared with arterio-venous shunting or totally implantable devices used by other authors.

摘要

化疗通常持续数月,需要良好的血管通路。反复注射细胞毒性药物对外周静脉有害。我们在此报告一项针对98例门诊患者的前瞻性研究,这些患者在给药期间留置了隧道式中心静脉导管。导管可插入锁骨下静脉或颈内静脉。在化疗药物注射期间,每周在导管内给予一次肝素。该技术具有多项优点:药物注射简便、患者舒适度高、发生堵塞时可在其他部位重新插入、成本低。自5年前以来,该技术在居里研究所已成为“常规操作”。将该技术的优缺点与其他作者使用的动静脉分流术或完全植入式装置进行了比较。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验